February 28, 2019: Proton Partners International Limited (“The Company”) has listed on the NEX Exchange Growth Market.
February 4, 2019 – The first NHS Wales cancer patient to receive proton beam therapy in Wales has started treatment at the Rutherford Cancer Centre South Wales in Newport.
23rd January 2019: The Rutherford Cancer Centres welcome the news that the provision of proton beam therapy is to be more widely available following the start of treatment of a young cancer patient today at The Christie NHS Foundation Trust based in Manchester.
8th January 2019: Work began today on one of the most advanced healthcare diagnostic centres to be built in the UK.
11th December 2018: Proton Partners International announced today that the Rutherford Cancer Centre South Wales has been approved by the Welsh Health Specialised Services Committee (WHSSC) to provide high energy proton beam therapy to adult patients referred from the NHS in Wales.
27th November 2018: A new report by the Health Foundation has rightly highlighted the urgent need for a revolution in cancer diagnosis in Britain, Proton Partners International said today.
13th November 2018: A court case in the United States which ended in a £20 million damages award for the family of a patient who died from cancer after being denied proton beam therapy (PBT) has highlighted the importance of recognising PBT as a well-established treatment.
8th November 2018: The demand for proton beam therapy for cancer patients has increased significantly this year as a result of the availability of the treatment in the UK.
18th October 2018 – Medical innovation in the UK was given a significant boost today with the announcement that an advanced diagnostics centre is to be built in Liverpool.